Literature DB >> 12796552

A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome.

Marco Crimi1, Sara Galbiati, Isabella Moroni, Andreina Bordoni, Maria Paola Perini, Eleonora Lamantea, Monica Sciacco, Massimo Zeviani, Ida Biunno, Maurizio Moggio, Guglielmo Scarlato, Giacomo Pietro Comi.   

Abstract

A 13084 A->T missense mutation in the mitochondrial ND5 gene was identified in a 16-year-old boy affected with a progressive neurodegenerative disorder combining features of Leigh and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) syndromes. Muscle biopsy analysis revealed partial complex I deficiency. The mutation presented a variable degree of heteroplasmy in the patient's tissues. This finding underlines the contribution of mtDNA-encoded complex I subunits in the etiology of complex I deficiency associated with encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796552     DOI: 10.1212/01.wnl.0000066048.72780.69

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Authors:  Akira Sudo; Shiho Honzawa; Ikuya Nonaka; Yu-Ichi Goto
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

Review 2.  Mitochondrial complex I: structure, function and pathology.

Authors:  Rolf J R J Janssen; Leo G Nijtmans; Lambert P van den Heuvel; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

3.  Mitochondrial DNA mutations in late-onset Leigh syndrome.

Authors:  Yanping Wei; Liying Cui; Bin Peng
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

Review 4.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 6.  Differential diagnosis of chorea.

Authors:  Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

7.  A MELAS syndrome family harboring two mutations in mitochondrial genome.

Authors:  Byung-Ok Choi; Jung Hee Hwang; Joonki Kim; Eun Min Cho; Sun Young Cho; Su Jin Hwang; Hyang Woon Lee; Song Ja Kim; Ki Wha Chung
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

8.  The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype.

Authors:  M L Valentino; P Barboni; C Rengo; A Achilli; A Torroni; R Lodi; C Tonon; B Barbiroli; F Fortuna; P Montagna; A Baruzzi; V Carelli
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

9.  A rapid screening with direct sequencing from blood samples for the diagnosis of Leigh syndrome.

Authors:  Hiroko Shimbo; Mariko Takagi; Mitsuko Okuda; Yu Tsuyusaki; Kyoko Takano; Mizue Iai; Sumimasa Yamashita; Kei Murayama; Akira Ohtake; Yu-Ichi Goto; Noriko Aida; Hitoshi Osaka
Journal:  Mol Genet Metab Rep       Date:  2014-04-01

10.  MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant Load.

Authors:  Yi Shiau Ng; Nichola Z Lax; Paul Maddison; Charlotte L Alston; Emma L Blakely; Philippa D Hepplewhite; Gillian Riordan; Surita Meldau; Patrick F Chinnery; Germaine Pierre; Efstathia Chronopoulou; Ailian Du; Imelda Hughes; Andrew A Morris; Smaragda Kamakari; Georgia Chrousos; Richard J Rodenburg; Christiaan G J Saris; Catherine Feeney; Steven A Hardy; Takafumi Sakakibara; Akira Sudo; Yasushi Okazaki; Kei Murayama; Helen Mundy; Michael G Hanna; Akira Ohtake; Andrew M Schaefer; Mike P Champion; Doug M Turnbull; Robert W Taylor; Robert D S Pitceathly; Robert McFarland; Gráinne S Gorman
Journal:  EBioMedicine       Date:  2018-02-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.